Annovis Bio
ANVS
42 hedge funds and large institutions have $4.19M invested in Annovis Bio in 2025 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 5 closing their positions.
87% more call options, than puts
Call options by funds: $419K | Put options by funds: $224K
25% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 8
7% more capital invested
Capital invested by funds: $3.93M → $4.19M (+$260K)
1.09% more ownership
Funds ownership: 9.3% → 10.39% (+1.1%)
0% more funds holding
Funds holding: 42 → 42 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$362K |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$154K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$135K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$103K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$72.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$197K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$64.2K |
| 3 |
Jane Street
New York
|
-$51.6K |
| 4 |
MFG
Merit Financial Group
Alpharetta,
Georgia
|
-$25K |
| 5 |
CAMG
CWA Asset Management Group
Naples,
Florida
|
-$15K |
ANVS Hedge Fund Activity: Q3 2025 in Review
42 of the 7,641 institutional investors tracked by Wall St. Rank reported a position in Annovis Bio (ANVS) for Q3 2025, worth a combined $4.19M — up 6.6% from $3.93M a quarter earlier.
Fund positioning in ANVS was balanced in Q3 2025: 5 funds opened new positions, 5 closed out, 10 added to existing stakes and 8 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $362K. The largest seller was Marshall Wace, exiting entirely with an estimated $197K sold.
- 42 institutional investors held Annovis Bio (ANVS) as of Q3 2025, unchanged from Q2 2025.
- Funds reported $4.19M of Annovis Bio stock for Q3 2025, up 6.6% quarter-over-quarter.
- 5 funds opened new Annovis Bio positions in Q3 2025 and 5 closed out, a net change of 0 holders.
- The largest Annovis Bio buyer in Q3 2025 was Citadel Advisors, an estimated $362K added.
- The largest Annovis Bio seller in Q3 2025 was Marshall Wace, an estimated $197K sold.
Based on aggregated 13F filings for Q3 2025.